Roivant Sciences Ltd. Warrant

YTD

ALL

Why Robinhood?

You can watch ROIVW and buy or sell other stocks, ETFs, and their options commission-free!

About ROIVW

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses.

CEO

Matthew Gline

CEOMatthew Gline

Employees

—

Employees—

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2014

Founded2014

Employees

—

Employees—

ROIVW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

46.79K

Average volume46.79K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$4.00

52 Week high$4.00

52 Week low

$0.2181

52 Week low$0.2181